| For: | Eghtesadi-Araghi P, Sohrabpour AA, Vahedi H, Saberi-Firoozi M. Halothane hepatitis in Iran: A review of 59 cases. World J Gastroenterol 2008; 14(34): 5322-5326 [PMID: 18785286 DOI: 10.3748/wjg.14.5322] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v14/i34/5322.htm |
| Number | Citing Articles |
| 1 |
Patrick J. Shaw, Patricia E. Ganey, Robert A. Roth. Idiosyncratic Drug-Induced Liver Injury and the Role of Inflammatory Stress with an Emphasis on an Animal Model of Trovafloxacin Hepatotoxicity. Toxicological Sciences 2010; 118(1) doi: 10.1093/toxsci/kfq168
|
| 2 |
J. Aubert, K. Begriche, L. Knockaert, M.A. Robin, B. Fromenty. Increased expression of cytochrome P450 2E1 in nonalcoholic fatty liver disease: Mechanisms and pathophysiological role. Clinics and Research in Hepatology and Gastroenterology 2011; 35(10) doi: 10.1016/j.clinre.2011.04.015
|
| 3 |
Charles M. Skinner, Isabelle R. Miousse, Laura E. Ewing, Vijayalakshmi Sridharan, Maohua Cao, Haixia Lin, D. Keith Williams, Bharathi Avula, Saqlain Haider, Amar G. Chittiboyina, Ikhlas A. Khan, Mahmoud A. ElSohly, Marjan Boerma, Bill J. Gurley, Igor Koturbash. Impact of obesity on the toxicity of a multi-ingredient dietary supplement, OxyELITE Pro™ (New Formula), using the novel NZO/HILtJ obese mouse model: Physiological and mechanistic assessments. Food and Chemical Toxicology 2018; 122 doi: 10.1016/j.fct.2018.09.067
|
| 4 |
Gary C. Kanel, Jacob Korula. Atlas of Liver Pathology. 2011; doi: 10.1016/B978-1-4377-0765-6.10005-9
|
| 5 |
Takahiro Tamura, Takahiro Ando. Environmental and clinical rationale for the use of desflurane: a review of the literature. Journal of Anesthesia 2026; doi: 10.1007/s00540-026-03760-6
|
| 6 |
Christine M. Dugan, Allen E. MacDonald, Robert A. Roth, Patricia E. Ganey. A Mouse Model of Severe Halothane Hepatitis Based on Human Risk Factors. The Journal of Pharmacology and Experimental Therapeutics 2010; 333(2) doi: 10.1124/jpet.109.164541
|
| 7 |
Connie Y. Chang, Elisabeth Goldstein, Nitin Agarwal, Kenneth G. Swan. Ether in the developing world: rethinking an abandoned agent. BMC Anesthesiology 2015; 15(1) doi: 10.1186/s12871-015-0128-3
|
| 8 |
Christine M. Dugan, Aaron M. Fullerton, Robert A. Roth, Patricia E. Ganey. Natural Killer Cells Mediate Severe Liver Injury in a Murine Model of Halothane Hepatitis. Toxicological Sciences 2011; 120(2) doi: 10.1093/toxsci/kfr005
|
| 9 |
|
| 10 |
Fernando Bessone, Melisa Dirchwolf, María Agustina Rodil, María Valeria Razori, Marcelo G. Roma. Review article: drug‐induced liver injury in the context of nonalcoholic fatty liver disease – a physiopathological and clinical integrated view. Alimentary Pharmacology & Therapeutics 2018; 48(9) doi: 10.1111/apt.14952
|
| 11 |
Ali Akbar Velayati. Hospitalization, Diagnosis, Treatment, and Surgery in Iran. 2023; doi: 10.1016/B978-0-443-15305-1.00005-X
|
| 12 |
Shivakumar Chitturi, Geoffrey C. Farrell. Schiff's Diseases of the Liver. 2011; doi: 10.1002/9781119950509.ch27
|
| 13 |
Kira L. Newman, Kay M. Johnson, Paul B. Cornia, Peter Wu, Kamal Itani, George N. Ioannou. Perioperative Evaluation and Management of Patients With Cirrhosis: Risk Assessment, Surgical Outcomes, and Future Directions. Clinical Gastroenterology and Hepatology 2020; 18(11) doi: 10.1016/j.cgh.2019.07.051
|
| 14 |
Karima Begriche, Julie Massart, Marie-Anne Robin, Annie Borgne-Sanchez, Bernard Fromenty. Drug-induced toxicity on mitochondria and lipid metabolism: Mechanistic diversity and deleterious consequences for the liver. Journal of Hepatology 2011; 54(4) doi: 10.1016/j.jhep.2010.11.006
|
| 15 |
Wei Zou, Robert A. Roth, Patricia E. Ganey. Encyclopedia of Drug Metabolism and Interactions. 2012; doi: 10.1002/9780470921920.edm088
|
| 16 |
Jonathan Lin, David Moore, Brad Hockey, Rachel Di Lernia, Alexandra Gorelik, Danny Liew, Amanda Nicoll. Drug‐induced hepatotoxicity: incidence of abnormal liver function tests consistent with volatile anaesthetic hepatitis in trauma patients. Liver International 2014; 34(4) doi: 10.1111/liv.12278
|
| 17 |
Jonathon E. Kivela, Toby N. Weingarten, Juraj Sprung. A Case Approach to Perioperative Drug-Drug Interactions. 2015; doi: 10.1007/978-1-4614-7495-1_26
|
| 18 |
Xu Li, Pujun Gao, Junqi Niu. Metabolic Comorbidities and Risk of Development and Severity of Drug-Induced Liver Injury. BioMed Research International 2019; 2019 doi: 10.1155/2019/8764093
|
| 19 |
Winnie Ng, Alexandra R.M. Lobach, Xu Zhu, Xin Chen, Feng Liu, Imir G. Metushi, Amy Sharma, Jinze Li, Ping Cai, Julia Ip, Maria Novalen, Marija Popovic, Xiaochu Zhang, Tadatoshi Tanino, Tetsuya Nakagawa, Yan Li, Jack Uetrecht. Current Concepts in Drug Metabolism and Toxicology. Advances in Pharmacology 2012; 63 doi: 10.1016/B978-0-12-398339-8.00003-3
|
| 20 |
Bridget Bishop, Nicholas Hannah, Adam Doyle, Francesco Amico, Brad Hockey, David Moore, Siddharth Sood, Alexandra Gorelik, Danny Liew, Dolores Njoku, Amanda Nicoll. A prospective study of the incidence of drug‐induced liver injury by the modern volatile anaesthetics sevoflurane and desflurane. Alimentary Pharmacology & Therapeutics 2019; 49(7) doi: 10.1111/apt.15168
|
| 21 |
Youn Joung Cho, Young Jae Park, Se Hee Min, Ho-Geol Ryu. The Effect of General Anesthesia on Aminotransferase Levels in Patients with Elevated Aminotransferase Levels. Anesthesia & Analgesia 2015; 121(6) doi: 10.1213/ANE.0000000000001030
|
| 22 |
Ana Paula Madariaga-Traconis, Mirna Daniela Gamez-Castro, Varenka Julieta Barbero-Becerra. El papel de los anestésicos en el daño hepático. Revista Mexicana de Anestesiología 2025; 48(2) doi: 10.35366/119203
|